- Home
- CCSI vs ZBIO Comparison
CCSI vs ZBIO Comparison
Compare CCSI & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- ZBIO
- Stock Information
- Founded
- CCSI 2021
- ZBIO 2019
- Country
- CCSI United States
- ZBIO United States
- Employees
- CCSI N/A
- ZBIO N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- ZBIO
- Sector
- CCSI Technology
- ZBIO
- Exchange
- CCSI Nasdaq
- ZBIO NYSE
- Market Cap
- CCSI 475.1M
- ZBIO 389.2M
- IPO Year
- CCSI N/A
- ZBIO 2024
- Fundamental
- Price
- CCSI $22.36
- ZBIO $9.61
- Analyst Decision
- CCSI Hold
- ZBIO Strong Buy
- Analyst Count
- CCSI 5
- ZBIO 7
- Target Price
- CCSI $27.20
- ZBIO $32.29
- AVG Volume (30 Days)
- CCSI 163.7K
- ZBIO 132.9K
- Earning Date
- CCSI 05-07-2025
- ZBIO 05-15-2025
- Dividend Yield
- CCSI N/A
- ZBIO N/A
- EPS Growth
- CCSI N/A
- ZBIO N/A
- EPS
- CCSI 4.32
- ZBIO N/A
- Revenue
- CCSI $349,374,000.00
- ZBIO $15,000,000.00
- Revenue This Year
- CCSI $1.20
- ZBIO N/A
- Revenue Next Year
- CCSI $0.56
- ZBIO N/A
- P/E Ratio
- CCSI $5.20
- ZBIO N/A
- Revenue Growth
- CCSI N/A
- ZBIO N/A
- 52 Week Low
- CCSI $15.81
- ZBIO $5.83
- 52 Week High
- CCSI $32.10
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- CCSI 53.13
- ZBIO N/A
- Support Level
- CCSI $20.86
- ZBIO N/A
- Resistance Level
- CCSI $22.90
- ZBIO N/A
- Average True Range (ATR)
- CCSI 0.78
- ZBIO 0.00
- MACD
- CCSI -0.08
- ZBIO 0.00
- Stochastic Oscillator
- CCSI 55.76
- ZBIO 0.00
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.